In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Dompe Farmaceutici SPA

www.dompe.com

Latest From Dompe Farmaceutici SPA

Kiadis Raises €28m As Cell Therapy Nears Commercialization

The funding comes as the Dutch biotech closes in on a potential conditional approval and closure of its acquisition of CytoSen.

Financing ImmunoOncology

Australian Orphan Fee Waivers To Expire As Transition Period Ends

The transition period for Australia’s new orphan drug program is coming to an end, and sponsors may need to take action if they want to keep their orphan status - and fee waivers - beyond the end of June. 
Rare Diseases Australia

BMS Scoops Cormorant In $520M Immuno-Oncology Deal

Bristol-Myers Squibb Co. has bolstered its immuno-oncology ambitions by acquiring IL-8 focused Cormorant Pharmaceuticals AB, the 4-year old Swedish biotech. Cormorant’s shareholders are getting $95M up front with the promise of a further $425M if milestones are achieved.

BioPharmaceutical Clinical Trials

BMS Scoops Cormorant In $520M Immuno-Oncology Deal

Bristol-Myers Squibb Co. has bolstered its immuno-oncology ambitions by acquiring IL-8 focused Cormorant Pharmaceuticals AB, the 4-year old Swedish biotech. Cormorant’s shareholders are getting $95M up front with the promise of a further $425M if milestones are achieved.

Companies M & A
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Italy
  • Company Type
  • Midsize European
  • Parent & Subsidiaries
  • Dompe Farmaceutici SPA
  • Senior Management
  • Eugenio Aringhieri, CEO
    Guiseppe Andreano, CFO
    Sergio Dompe, Pres.
    Marcello Allegretti, Dir., R&D
  • Contact Info
  • Dompe Farmaceutici SPA
    Phone: (39) 2 583 831
    Via San Martino 12
    Milan, 20122
    Italy
Advertisement
Advertisement
UsernamePublicRestriction

Register